A multidisciplinary team, made up of diagnosticians and treatment specialists, examines the power of genomic technologies to inform clinical decisions for the treatment of patients with brain tumors.
Francisco Quintana, PhD, of the Ann Romney Center for Neurologic Diseases, and colleagues have…
Rebecca Amariglio, PhD, of the Center for Alzheimer Research and Treatment in BWH’s Department of…
Dennis Selkoe, MD, a leader in Alzheimer’s disease research, shares insights on the scientific discoveries and research pursuits that have led to important progress and momentum in the field.
Mariano Viapiano, PhD, looks for insights into malignant brain tumors by studying the neural microenvironment.
Check out tweets and highlights from the inaugural World Medical Innovation Forum.
The WEB Aneurysm Embolization System offers a solution for some patients.
Rose Du, MD, PhD, finds the beauty in both brain research and patient treatment.
A study led by Francisco J. Quintana, PhD, BWH Department of Neurology, found increased levels of the…
Dedicated clinic delivers multidisciplinary care for patients with Raynaud’s phenomenon.
A study led by Gad Marshall, MD, BWH Center for Alzheimer Research and Treatment, found that decreased…
A study led by Samia J. Khoury, MD, BWH Department of Neurology, discovered that the drug natalizumab…
A research team led by Dennis Selkoe, MD, Center for Neurologic Diseases, BWH Department of Neurology,…
A study led by Tracy L. Young-Pearse, PhD, is the first of its kind to examine the effects of antibody therapy on human neurons derived directly from patients with familial AD.
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.
Notify me of new posts via email.
Basic HTML is allowed. Your email address will not be published.
Subscribe to this comment feed via RSS